These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12594447)

  • 21. [Combination therapy with PDE III inhibitor for heart failure].
    Watanabe H; Kajimoto K; Kawana M
    Nihon Rinsho; 2007 May; 65 Suppl 5():134-9. PubMed ID: 17571377
    [No Abstract]   [Full Text] [Related]  

  • 22. Overview of emerging pharmacologic agents for acute heart failure syndromes.
    De Luca L; Mebazaa A; Filippatos G; Parissis JT; Böhm M; Voors AA; Nieminen M; Zannad F; Rhodes A; El-Banayosy A; Dickstein K; Gheorghiade M
    Eur J Heart Fail; 2008 Feb; 10(2):201-13. PubMed ID: 18279775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure.
    Aronson D; Burger AJ
    Am Heart J; 2004 Nov; 148(5):e16. PubMed ID: 15523294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function.
    Cioffi G; Tarantini L; Stefenelli C; Azzetti G; Marco R; Carlucci S; Furlanello F
    J Card Fail; 2006 Oct; 12(8):608-15. PubMed ID: 17045179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasodilators in the management of acute heart failure.
    Elkayam U; Janmohamed M; Habib M; Hatamizadeh P
    Crit Care Med; 2008 Jan; 36(1 Suppl):S95-105. PubMed ID: 18158484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasodilator therapy for decompensated heart failure.
    Yancy CW
    J Am Coll Cardiol; 2008 Jul; 52(3):208-10. PubMed ID: 18617069
    [No Abstract]   [Full Text] [Related]  

  • 28. Considerations on the efficacy and safety of levosimendan in ischemic heart failure.
    Nieminen MS; Sandell EP
    Ital Heart J; 2003 May; 4 Suppl 2():39S-44S. PubMed ID: 14635369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nesiritide--not verified.
    Schreiner G
    N Engl J Med; 2005 Oct; 353(14):1525-7; author reply 1525-7. PubMed ID: 16211709
    [No Abstract]   [Full Text] [Related]  

  • 30. Concomitant use of nesiritide and milrinone in decompensated congestive heart failure.
    Smull DL; Jorde UP
    Am J Health Syst Pharm; 2005 Feb; 62(3):291-5. PubMed ID: 15719588
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute decompensated heart failure: the shrinking role of inotropic therapy.
    Dec GW
    J Am Coll Cardiol; 2005 Jul; 46(1):65-7. PubMed ID: 15992637
    [No Abstract]   [Full Text] [Related]  

  • 32. Nesiritide - not verified.
    Topol EJ
    N Engl J Med; 2005 Jul; 353(2):113-6. PubMed ID: 16014879
    [No Abstract]   [Full Text] [Related]  

  • 33. Acute effects of intravenous nicorandil on hemodynamics in patients hospitalized with acute decompensated heart failure.
    Tanaka K; Kato K; Takano T; Katagiri T; Asanoi H; Nejima J; Nakashima M; Kamijo T; Sakanashi M
    J Cardiol; 2010 Nov; 56(3):291-9. PubMed ID: 20709498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
    Botha P; Parry G; Dark JH; Macgowan GA
    J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sodium nitroprusside for advanced low-output heart failure.
    Mullens W; Abrahams Z; Francis GS; Skouri HN; Starling RC; Young JB; Taylor DO; Tang WH
    J Am Coll Cardiol; 2008 Jul; 52(3):200-7. PubMed ID: 18617068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beneficial effects of early initiation of vasoactive agents in patients with acute decompensated heart failure.
    Saltzberg MT
    Rev Cardiovasc Med; 2004; 5 Suppl 4():S17-27. PubMed ID: 15627915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acetylation status does not affect levosimendan's hemodynamic effects in heart failure patients.
    Kivikko M; Sundberg S; Karlsson MO; Pohjanjousi P; Colucci WS
    Scand Cardiovasc J; 2011 Apr; 45(2):86-90. PubMed ID: 21133820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of nesiritide to treat acute decompensated heart failure.
    Hachey DM; Smith T
    Crit Care Nurse; 2003 Feb; 23(1):53-5. PubMed ID: 12640959
    [No Abstract]   [Full Text] [Related]  

  • 39. Levosimendan: dual mechanisms for acute heart failure...and beyond?
    Ng TM; Akhter MW
    Minerva Cardioangiol; 2005 Dec; 53(6):565-84. PubMed ID: 16333239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overview of current noninodilator therapies for acute heart failure syndromes.
    Stough WG; O'Connor CM; Gheorghiade M
    Am J Cardiol; 2005 Sep; 96(6A):41G-6G. PubMed ID: 16181822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.